Compare ANIK & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIK | RCMT |
|---|---|---|
| Founded | 1983 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.9M | 196.0M |
| IPO Year | 1996 | 1997 |
| Metric | ANIK | RCMT |
|---|---|---|
| Price | $14.82 | $21.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $17.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 91.7K | 69.6K |
| Earning Date | 04-29-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.16 | 27.38 |
| EPS | N/A | ★ 0.52 |
| Revenue | $112,819,000.00 | ★ $186,737,000.00 |
| Revenue This Year | $5.98 | $11.89 |
| Revenue Next Year | $7.42 | $12.46 |
| P/E Ratio | ★ N/A | $10.16 |
| Revenue Growth | N/A | ★ 5.83 |
| 52 Week Low | $7.90 | $17.26 |
| 52 Week High | $16.24 | $32.50 |
| Indicator | ANIK | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 28.02 |
| Support Level | $13.95 | $21.22 |
| Resistance Level | $15.01 | $25.31 |
| Average True Range (ATR) | 0.54 | 1.63 |
| MACD | -0.00 | -1.18 |
| Stochastic Oscillator | 42.09 | 8.60 |
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.